1AI — Algorae Pharmaceuticals Income Statement
0.000.00%
Last trade - 00:00- AU$8.44m
- AU$6.03m
- AU$0.13m
Annual income statement for Algorae Pharmaceuticals, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.554 | 0.268 | 0.003 | 0.042 | 0.125 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 3.3 | 2.28 | 2.39 | 2.13 | 2.2 |
| Operating Profit | -2.74 | -2.01 | -2.38 | -2.09 | -2.08 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -1.35 | -1.91 | -2.37 | -2.11 | -2.1 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -0.968 | -1.46 | -1.96 | -2.11 | -2.1 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -0.968 | -1.46 | -1.96 | -2.11 | -2.1 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -0.968 | -1.46 | -1.96 | -2.11 | -2.1 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.001 | -0.002 | -0.002 | -0.002 | -0.001 |